600267 海正藥業
按盤價 
11.390 +1.040 (+10.048%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.381 | 7.312 | -1.152 | 6.356 | 6.969 |
| 總資產報酬率 ROA (%) | 3.486 | 3.580 | -0.512 | 2.563 | 2.422 |
| 投入資產回報率 ROIC (%) | 4.307 | 4.374 | -0.636 | 3.196 | 3.062 | 邊際利潤分析 |
| 銷售毛利率 (%) | 44.834 | 42.456 | 41.542 | 44.222 | 42.736 |
| 營業利潤率 (%) | 8.219 | 6.976 | 0.890 | 5.998 | 6.050 |
| 息稅前利潤/營業總收入 (%) | 8.526 | 8.191 | 1.082 | 8.315 | 8.429 |
| 淨利潤/營業總收入 (%) | 5.190 | 5.719 | -0.965 | 4.317 | 4.415 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 134.778 | 107.212 | -278.042 | 113.401 | 99.273 |
| 價值變動淨收益/利潤總額(%) | -8.767 | 19.849 | -90.002 | -11.155 | 13.427 |
| 營業外收支淨額/利潤總額(%) | -6.336 | -0.454 | 207.936 | 0.138 | -8.674 | 償債能力分析 |
| 流動比率 (X) | 0.928 | 0.922 | 0.966 | 0.899 | 0.724 |
| 速動比率 (X) | 0.638 | 0.630 | 0.669 | 0.630 | 0.494 |
| 資產負債率 (%) | 41.191 | 46.289 | 52.596 | 55.638 | 62.086 |
| 帶息債務/全部投入資本 (%) | 26.893 | 34.150 | 41.745 | 43.843 | 50.530 |
| 股東權益/帶息債務 (%) | 265.322 | 187.257 | 134.380 | 124.129 | 91.799 |
| 股東權益/負債合計 (%) | 138.829 | 112.821 | 87.458 | 77.330 | 60.715 |
| 利息保障倍數 (X) | 10.703 | 6.569 | 0.568 | 3.601 | 2.945 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 60.812 | 64.245 | 78.290 | 71.945 | 57.943 |
| 存貨周轉天數 (天) | 107.670 | 113.488 | 118.569 | 111.653 | 124.618 |
| 備註： | 即時報價更新時間為 15/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
